Voraratt Champattanachai
4PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 10, 2026
Reducing OGT and O-GlcNAcylation enhance the anticancer effects of oxaliplatin in SW620 metastatic colorectal cancer cells.Thirasak Bunsuk, Juthamard Chantaraamporn, Photsathorn Mutapat
|Apr 06, 2023
Label-free quantitative proteomics reveals aberrant expression levels of LRG, C9, FN, A1AT and AGP1 in the plasma of patients with colorectal cancer.Chris Verathamjamras, Juthamard Chantaraamporn, Thiwaree Sornprachum
|Feb 20, 2021
Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer.Chris Verathamjamras, Tanin-Ek Sriwitool, Pukkavadee Netsirisawan
|Sep 25, 2020
Glycoproteomic Analysis Reveals Aberrant Expression of Complement C9 and Fibronectin in the Plasma of Patients with Colorectal Cancer.Juthamard Chantaraamporn, Voraratt Champattanachai, Amnart Khongmanee
Pageof 1
